Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
10/2002
10/10/2002WO2001093845A3 Carboxyalkylether-acat inhibitor combinations
10/10/2002WO2001077174A3 Human transporters and ion channels
10/10/2002WO2001072728A9 Novel piperazine derivatives
10/10/2002WO2001053324A8 Novel haptotactic peptides
10/10/2002US20020147999 Reducing neuronal tangles in alzhemier's patients; obtain human, administer modulator, monitor development of neuronal tangles in, reduction in neuronal tangles indicates modulator
10/10/2002US20020147346 New crystal modification of torasemide
10/10/2002US20020147341 Kinase inhibitor; benign prostatic hyperplasia
10/10/2002US20020147339 5-cyano-2-aminopyrimidine derivatives
10/10/2002US20020147338 Pyrazolotriazines as CRF antagonists
10/10/2002US20020147239 Esmolol formulation
10/10/2002US20020147238 Methods and compositions for the treatment of neuropathic pain, tinnitus, and other disorders using R(-)-ketoprofen
10/10/2002US20020147231 Allosteric adenosine receptor modulators
10/10/2002US20020147224 2-oxo-imidazolidine-4-carboxylic acid hydroxamide compounds that inhibit matrix metalloproteinases
10/10/2002US20020147222 Brain disorders; Alzheimer's disease
10/10/2002US20020147220 Norcisapride; sleep disorders, eating disorders, irratible bowel disorders
10/10/2002US20020147218 Ethanolates of sodium-hydrogen exchanger type-1 inhibitor
10/10/2002US20020147209 Cycloalkano-indole and -azaindole derivatives
10/10/2002US20020147205 Heterocyclic compounds
10/10/2002US20020147203 Tyrosine kinase inhibitors
10/10/2002US20020147198 Substituted arylamine derivatives and methods of use
10/10/2002US20020147195 Piperidine derivatives and anti-platelet agents containing the same
10/10/2002US20020147192 Viricides; antiinflammatory agents; antiallergens; antiarthritic agents
10/10/2002US20020147185 Antihypoxic agents, antiischamic agents, antiarrhythmia agents
10/10/2002US20020147184 Combinations of sterol absorption inhibitor(s) with blood modifier(s) for treating vascular conditions
10/10/2002US20020147176 Thermoplastic and water-soluble cellulose ether esters
10/10/2002US20020147158 Composition and method for preventing and treating sinusoidal obstruction syndrome and radiation-induced liver disease
10/10/2002US20020147157 Combination therapy comprising anti-diabetic and anticonvulsant agents
10/10/2002US20020147142 Methods and reducing or maintaining reduced levels of blood lipids using OB protein compositions
10/10/2002US20020147131 Metabolic intervention with GLP-1 to improve the function of ischemic and reperfused skeletal muscle tissue
10/10/2002US20020146792 Nucleotide sequences coding protein for use in the treatment of atherosclerosis
10/10/2002US20020146678 Determining preferential gene expression pattern in embryonic cells; obtain cells, monitor gene expresion products, incubate with animal growth regulators, monitor gene expresion pattern and differentiation in cells
10/10/2002US20020146471 For maintenance of a state of wellness in which sexual health is improved
10/10/2002US20020146466 Solid form compositions containing an extract of a raw material as the active ingredient and process of preparing the same
10/10/2002US20020146417 Administering function blocking antibody or a fragment antibody, capable of binding an epitope of VLA-1 to provide a decrease in arthritic score of about 65% or greater when compared to control antibody treated subject
10/10/2002US20020146416 Human trk receptors and neurotrophic factor inhibitors
10/10/2002US20020146414 Controlled release of non heparin-binding growth factors from heparin-containing matrices
10/10/2002US20020146405 Treatment of hibernating myocardium and diabetic cardiomyopathy with a GLP-1 peptide
10/10/2002US20020146386 In vivo use of water absorbent polymers
10/10/2002DE10117183A1 Verwendung von substituierten Imidazo[1,2-a]-pyridinverbindungen als Arzneimittel Use of substituted imidazo [1,2-a] -pyridinverbindungen as medicaments
10/10/2002DE10115922A1 Cyclisch substituierte 2-Thio-3,5-dicyano-4-aryl-6-aminopyridine und ihre Verwendung Cyclic substituted 2-thio-3,5-dicyano-4-aryl-6-aminopyridines and their use
10/10/2002DE10115073A1 Verwendung von Inhibitoren von IKK-ß und Verfahren zum Auffinden solcher Inhibitoren Use of inhibitors of IKK-ß and methods for finding such inhibitors
10/10/2002DE10114775A1 2-Mercapto-4,5-diarylimidazolderivate und ihre Verwendung in der Pharmazie 2-mercapto-4,5-diarylimidazolderivate and their use in the pharmaceutical
10/10/2002CA2443050A1 Immunomodulation and effect on cell processes relating to serotonin family receptors
10/10/2002CA2442827A1 "a method for the preparation of immunologically inert amniotic membranes"
10/10/2002CA2442798A1 Antioxidant nitroxides and nitrones as therapeutic agents
10/10/2002CA2442775A1 New polynucleotides and polypeptides of the ifn alpha-21 gene
10/10/2002CA2442525A1 Cyclopropylindole derivatives as selective serotonin reuptake inhibitors
10/10/2002CA2442484A1 Cyano-substituted dihydropyrimidine compounds and their use to treat diseases
10/10/2002CA2442482A1 Novel cyano-substituted dihydropyrimidine compounds and their use to treat diseases
10/10/2002CA2442476A1 Pyridazinone aldose reductase inhibitors
10/10/2002CA2442457A1 Carbon monoxide generating compounds for treatment of vascular, inflammatory and immune disorders
10/10/2002CA2442455A1 A method of treating proliferative diseases using eg5 inhibitors
10/10/2002CA2442365A1 Premixed amiodarone parenteral solution and method for making the same
10/10/2002CA2442328A1 Therapeutic combinations for cardiovascular and inflammatory indications
10/10/2002CA2442263A1 Substituted 2-carba-3,5-dicyano-4-aryl-6-aminopyridines and the use of the same as selective ligands of the adenosine receptor
10/10/2002CA2442150A1 Sapogenin derivatives, their synthesis and use, and methods based upon their use
10/10/2002CA2442106A1 Conjugated unsaturated glyceride mixtures and a method for producing the same
10/10/2002CA2442064A1 G-protein coupled receptors
10/10/2002CA2442062A1 Secreted proteins
10/10/2002CA2441654A1 Cytoskeleton-associated proteins
10/10/2002CA2441562A1 Short bioactive peptides and methods for their use
10/10/2002CA2441252A1 Estrogen replacement therapy
10/10/2002CA2441077A1 Substituted carbazoles as inhibitors of spla2
10/10/2002CA2440108A1 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
10/10/2002CA2439842A1 Gaba-receptor modulators for the treatment of neurodegenerative diseases of the eye
10/10/2002CA2438272A1 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same
10/10/2002CA2435390A1 Compositions, methods and apparatuses for singlet oxygen delivery
10/10/2002CA2429265A1 Mammalian alpha-helical protein-53
10/10/2002CA2429108A1 .psi..epsilon.rack peptide composition and method for protection against tissue damage due to ischemia
10/09/2002EP1247860A1 Crystal structure of pyruvate dehydrogenase kinase 2 (PDHK-2) and use thereof in methods for identifying and designing new ligands
10/09/2002EP1247810A1 Novel benzotriazoles anti-inflammatory compounds
10/09/2002EP1247809A2 Triazine compounds useful as sorbitol dehydrogenase inhibitors
10/09/2002EP1247803A2 Indolinone compounds suitable for modulation of protein kinases
10/09/2002EP1247523A1 Essential fatty acids in the prevention of cardiovascular events
10/09/2002EP1246932A1 Conjugated fatty acids and related compounds, and method for their enzymatic preparation
10/09/2002EP1246920A2 Prevention of affections associated with porcine circovirus-2
10/09/2002EP1246918A2 Secreted proteins
10/09/2002EP1246903A1 Reconstructing organs from decellularized biomaterial scaffold
10/09/2002EP1246847A2 Dna encoding a human melanin concentrating hormone receptor (mch1) and uses thereof
10/09/2002EP1246843A1 Novel fgf homolog zfgf12
10/09/2002EP1246842A1 Nk cell receptor polynucleotides, polypeptides, and antibodies
10/09/2002EP1246840A2 Human and parasite orphan receptor proteins
10/09/2002EP1246828A1 Benzosulfones with calcium antagonist activity
10/09/2002EP1246825A1 Fused pyrrole compounds, pharmaceutical agents containing the same, and the use thereof
10/09/2002EP1246824A1 Carboxamide diazepin derivatives, preparation method, use as medicines, pharmaceutical compositions and use thereof
10/09/2002EP1246823A1 Pyrimidine and triazine kinase inhibitors
10/09/2002EP1246808A1 1,2-diaryl benzimidazoles for treating illnesses associated with a microglia activation
10/09/2002EP1246807A2 Novel hydantoin, thiohydantoin, pyrimidinedione and thioxopyrimidinone derivatives, preparation method and use as medicines
10/09/2002EP1246804A1 4-carboxyamino-2-ethyl-1,2,3,4-tetrahydroquinoline crystal as cetp inhibitor
10/09/2002EP1246800A1 Beta-amino acid compounds as integrin antagonists
10/09/2002EP1246799A1 Substituted pyrrole mannich bases to combat pain and allergic reactions
10/09/2002EP1246793A2 Substituted aminomethyl-phenyl-cyclohexane derivatives
10/09/2002EP1246791A2 Aminomethyl-phenyl-cyclohexanone derivatives
10/09/2002EP1246790A1 Substituted 1 and 2 naphthol mannich bases
10/09/2002EP1246642A2 Use of a vector comprising a nucleic acid coding for an anti-angiogenic factor for treating corneal neovascularization
10/09/2002EP1246638A1 Use of exendins and agonists thereof for modulation of triglyceride levels and treatment of dyslipidemia
10/09/2002EP1246630A1 Compositions and methods for facilitating skin growth and managing skin conditions
10/09/2002EP1246629A1 Methods of using electron active compounds for managing cancer
10/09/2002EP1246627A2 Polyanhydrides with biologically active degradation products
10/09/2002EP1246623A1 Compounds specific to adenosine a1, a2a, and a3 receptor and uses thereof
1 ... 1083 1084 1085 1086 1087 1088 1089 1090 1091 1092 1093 1094 1095 1096 1097 1098 1099 1100 1101 1102 1103 ... 1595